Menu Search
Equities

Teleflex Inc

TFX:NYQ

Teleflex Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)191.23
  • Today's Change0.585 / 0.31%
  • Shares traded44.87k
  • 1 Year change-12.37%
  • Beta1.1617
Data delayed at least 15 minutes, as of Nov 22 2024 16:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform7
Hold8
Sell0
Strong Sell0

Share price forecast in USD

The 12 analysts offering 12 month price targets for Teleflex Inc have a median target of 245.00, with a high estimate of 285.00 and a low estimate of 214.00. The median estimate represents a 28.51% increase from the last price of 190.64.
High49.5%285.00
Med28.5%245.00
Low12.3%214.00

Dividends in USD

In 2023, Teleflex Inc reported a dividend of 1.36 USD, equaling last years dividend. The 4 analysts covering the company expect dividends of 1.36 USD for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Oct 31, 2024, Teleflex Inc reported 3rd quarter 2024 earnings of 3.49 per share. This result was in line with the consensus of the 13 analysts following the company and under-performed last year's 3rd quarter results by 4.12%.
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate-0.90%
Teleflex Inc reported annual 2023 earnings of 13.52 per share on Feb 22, 2024.
Average growth rate+5.53%
More ▼

Revenue history & estimates in USD

Teleflex Incorporated had 3rd quarter 2024 revenues of 764.38m. This missed the 769.60m consensus estimate of the 12 analysts following the company. This was 7.52% above the prior year's 3rd quarter results.
Average growth rate+0.65%
Teleflex Incorporated had revenues for the full year 2023 of 2.97bn. This was 6.57% above the prior year's results.
Average growth rate+3.60%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.